Atlas Trials

Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia

Clinical trial NCT06791824 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06791824
Sponsor
Keymed Biosciences Co.Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Aplastic Anemia
Start date
2025-03-01
Primary completion
2027-12-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.